(Q33961253)

30 July 2017

1 reference

title

Insulin-like effects of vanadium: basic and clinical implications (English)

1 reference

30 July 2017

1 reference

0 references

5

Shechter Y

1 reference

30 July 2017

Goldwaser I

1

1 reference

30 July 2017

Gefel D

series ordinal

2

1 reference

30 July 2017

Gershonov E

series ordinal

3

1 reference

30 July 2017

Fridkin M

series ordinal

4

1 reference

30 July 2017

publication date

1 May 2000

1 reference

Journal of Inorganic Biochemistry

30 July 2017

published in

1 reference

30 July 2017

volume

80

1 reference

30 July 2017

issue

1-2

1 reference

30 July 2017

page(s)

21-25

1 reference

Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl (IV) ions

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

Electron paramagnetic resonance studies and insulin-like effects of vanadium in rat adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

The nature and regulation of the insulin receptor: structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

Effects of Streptozotocin-induced Diabetes on Insulin Binding, Glucose Transport, and Intracellular Glucose Metabolism in Isolated Rat Adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

Sustained prevention of myocardial and metabolic abnormalities in diabetic rats following withdrawal from oral vanadyl treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

Long term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fa/fa rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

The insulin receptor and the molecular mechanism of insulin action

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

Inhibition of insulin-dependent lipogenesis and anti-lipolysis by protein tyrosine kinase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

Quercetin selectively inhibits insulin receptor function in vitro and the bioresponses of insulin and insulinomimetic agents in rat adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

A cytosolic protein tyrosine kinase in rat adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

Detection of a 60 kDa tyrosine-phosphorylated protein in insulin-stimulated hepatoma cells that associates with the SH2 domain of phosphatidylinositol 3-kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

The Fyn tyrosine kinase binds Irs-1 and forms a distinct signaling complex during insulin stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

Insulin induces tyrosine phosphorylation of JAK2 in insulin-sensitive tissues of the intact rat

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

Evidence for the Distinct Vanadyl(+4)-Dependent Activating System for Manifesting Insulin-Like Effects†

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

The oxidation of NADH by tetravalent vanadium

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

Activation of permeabilized HL60 cells by vanadate. Evidence for divergent signalling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

Vanadium salts as insulin substitutes: mechanisms of action, a scientific and therapeutic tool in diabetes mellitus research

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

Hydrophobic carriers of vanadyl ions augment the insulinomimetic actions of vanadyl ions in rat adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

Bis(maltolato)oxovanadium(IV) is a potent insulin mimic

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

Increased potency of vanadium using organic ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

Vanadium distribution in rats and DNA cleavage by vanadyl complex: implication for vanadium toxicity and biological effects

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV)

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

In vitro and in vivo anti-tumor activity of L-glutamic acid gamma-monohydroxamate against L1210 leukemia and B16 melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

Glutamic acid gamma-monohydroxamate and hydroxylamine are alternate substrates for Escherichia coli asparagine synthetase B.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

L-Glutamic acid gamma-monohydroxamate. A potentiator of vanadium-evoked glucose metabolism in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900035-0

7 January 2021

10.1016/S0162-0134(00)00035-0

Identifiers

DOI

1 reference

30 July 2017

1 reference